8-K/A XBRL

AMENDMENT NO 1

Company: Xenetic Biosciences, Inc.
Filed: March 19, 2025
Period of Report: March 19, 2025
Accession Number: 0001683168-25-001712

View Document ↗ View on SEC.gov ↗